Skip to content
JournalsWorldThe Global Research Discovery Platform
Login Sign Up
SCHOLARLY PUBLICATION ✓ Open Access

Pulmonary Pathology of Early-Phase 2019 Novel Coronavirus (COVID-19) Pneumonia in Two Patients With Lung Cancer

Sufang Tian, Weidong Hu, Li Niu, Huan Liu, Haibo Xu, Shu‐Yuan Xiao

📖 Journal of Thoracic Oncology → 📅 2020-02-27 🔗 DOI: 10.1016/j.jtho.2020.02.010
View Journal Profile → ⬇ Download PDF View Official Paper ↗

📄 Abstract

The abstract has not yet been added. Use the official source link for the complete publication record.

🔬 Related Research Papers

Journal of Thoracic Oncology

Updated Efficacy and Safety Data and Impact of the EML4-ALK Fusion Variant on the Efficacy of Alectinib in Untreated ALK-Positive Advanced Non–Small Cell Lung Cancer in the Global Phase III ALEX Study

D. Ross Camidge, Rafał Dziadziuszko et al. 2019-03-20 · Read paper → Journal of Thoracic Oncology

IMpower150 Final Overall Survival Analyses for Atezolizumab Plus Bevacizumab and Chemotherapy in First-Line Metastatic Nonsquamous NSCLC

Mark A. Socinski, Makoto Nishio et al. 2021-07-24 · Read paper → Journal of Thoracic Oncology

Atezolizumab in Combination With Carboplatin and Nab-Paclitaxel in Advanced Squamous NSCLC (IMpower131): Results From a Randomized Phase III Trial

Robert M. Jotte, Federico Cappuzzo et al. 2020-04-14 · Read paper → Journal of Thoracic Oncology

The IASLC Lung Cancer Staging Project: Proposals for the Revisions of the T Descriptors in the Forthcoming Eighth Edition of the TNM Classification for Lung Cancer

Ramón Rami–Porta, Vanessa Bolejack et al. 2015-06-24 · Read paper → Journal of Thoracic Oncology

The International Epidemiology of Lung Cancer: Geographical Distribution and Secular Trends

Danny R. Youlden, Susanna M. Cramb, Peter D. Baade 2008-08-01 · Read paper → Journal of Thoracic Oncology

PD-L1 Immunohistochemistry Comparability Study in Real-Life Clinical Samples: Results of Blueprint Phase 2 Project

Ming‐Sound Tsao, Keith M. Kerr et al. 2018-05-22 · Read paper → Journal of Thoracic Oncology

Checkpoint Inhibitors in Metastatic EGFR- Mutated Non–Small Cell Lung Cancer—A Meta-Analysis

Chee Khoon Lee, Johnathan Man et al. 2016-10-19 · Read paper → Journal of Thoracic Oncology

Hypofractionated Stereotactic Radiotherapy (HypoFXSRT) for Stage I Non-small Cell Lung Cancer: Updated Results of 257 Patients in a Japanese Multi-institutional Study

Hiroshi Onishi, Hiroki Shirato et al. 2007-07-01 · Read paper → Journal of Thoracic Oncology

The IASLC Lung Cancer Staging Project: A Proposal for a New International Lymph Node Map in the Forthcoming Seventh Edition of the TNM Classification for Lung Cancer

Valerie W. Rusch, Hisao Asamura et al. 2009-05-01 · Read paper → Journal of Thoracic Oncology

PD-L1 Immunohistochemistry Assays for Lung Cancer: Results from Phase 1 of the Blueprint PD-L1 IHC Assay Comparison Project

Fred R. Hirsch, Abigail McElhinny et al. 2016-11-29 · Read paper → Journal of Thoracic Oncology

Molecular Testing Guideline for Selection of Lung Cancer Patients for EGFR and ALK Tyrosine Kinase Inhibitors: Guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology

Neal Ian Lindeman, Philip T. Cagle et al. 2013-04-03 · Read paper → Journal of Thoracic Oncology

A Prospective, Molecular Epidemiology Study of EGFR Mutations in Asian Patients with Advanced Non–Small-Cell Lung Cancer of Adenocarcinoma Histology (PIONEER)

Yuankai Shi, Joseph S. K. Au et al. 2014-01-13 · Read paper →